Building Capacity along the Continuum from Prevention to Care and Treatment for | CDC RFA GH15 151002CONT16

Frequently Asked Questions (FAQs)

What is the title of this grant opportunity?

The opportunity is titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR."

Which federal agency is offering this opportunity?

The opportunity is from the Centers for Disease Control and Prevention (CDC).

Is this an open, competitive funding opportunity?

No. This announcement is explicitly structured as continuation funding and is not an open competition.

Who is eligible to receive this continuation funding?

Eligibility is effectively limited to organizations that were already funded under the prior award "CDC-RFA-GH15-1510" with the same program title and scope. While the eligibility field is listed broadly as "Others," the continuation-only language restricts funding to existing recipients of the earlier cooperative agreement.

Can a new organization apply if it was not funded under CDC-RFA-GH15-1510?

Generally, no. Because the notice is continuation-only, new applicants that were not previously funded under "CDC-RFA-GH15-1510" are not expected to be eligible to apply.

What type of funding instrument is being used?

The funding instrument is a cooperative agreement.

What does it mean that this is a cooperative agreement?

A cooperative agreement typically means CDC is expected to have substantial involvement in the project beyond what is typical for a standard grant. This can include collaboration on technical guidance, performance monitoring, strategic adjustments, and alignment with PEPFAR policies, targets, and reporting requirements.

What is the main program focus of this opportunity?

The program focuses on strengthening services across the full HIV continuum, from prevention through linkage to care, treatment initiation, and sustained retention in care for key populations in Central America under PEPFAR.

What is meant by "the continuum from prevention to care and treatment" in this context?

Based on the description provided, this refers to HIV programming that spans prevention activities, HIV testing and counseling, referral and linkage systems to connect individuals to clinical services after diagnosis, treatment initiation (including rapid initiation of antiretroviral therapy), and ongoing adherence and retention support.

Who are considered "key populations" under this Central America PEPFAR context?

The description indicates that "key populations" generally refers to groups disproportionately affected by HIV and who often face barriers to care due to stigma, discrimination, mobility, or legal and social constraints.

What kinds of activities might be supported under this program?

The opportunity description suggests activities may include strengthening community-based HIV prevention services; expanding or improving HIV testing and counseling approaches suited to key populations; improving referral systems and client navigation to link people who test positive to care; supporting rapid initiation of antiretroviral therapy; and reinforcing adherence and retention supports. The description also notes that programs commonly incorporate stigma reduction, rights-informed service delivery, data and surveillance strengthening, quality improvement, and partnerships with ministries of health and civil society organizations.

What geographic area does the opportunity cover?

The focus is the Central America region.

How does this opportunity relate to PEPFAR?

This opportunity sits within CDC's global health and HIV programming funded through PEPFAR (the U.S. President's Emergency Plan for AIDS Relief) and is intended to strengthen HIV prevention, care, and treatment capacity aligned with PEPFAR priorities.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.067.

What does CFDA 93.067 indicate?

The description notes that CFDA 93.067 corresponds to CDC infectious disease and related public health assistance programming, often including HIV-focused initiatives.

What is the activity category for this opportunity?

The activity category is health.

How much funding is available (award ceiling)?

The award ceiling is listed as 0. This commonly indicates that a specific maximum funding level is not being publicly stated in the announcement record, that it may vary by recipient, or that amounts are governed by internal allocations and continuation decisions rather than a competitive cap.

How many awards does CDC expect to make?

The number of expected awards is not specified in the record. This is consistent with continuation actions, which are typically tied to the number of existing recipients rather than a new cohort of awardees.

What is the purpose of issuing a continuation funding announcement?

As described, continuation funding announcements are used to provide additional funding to existing grantees to maintain momentum, continue implementation, and potentially scale or refine activities that were already approved and underway under the earlier cooperative agreement.

What are the key administrative dates listed for this opportunity?

The source record shows a creation date of 2015-09-18 and an original closing date of 2015-11-25.

What does the listed closing date mean for potential applicants?

The record indicates an original closing date of 2015-11-25, and the opportunity is continuation-only for prior recipients. Based on the information provided, this is not positioned as a current open application window for new applicants.

What is the prior funding opportunity number referenced by this notice?

The prior award referenced is "CDC-RFA-GH15-1510."

Why might the eligibility field say "Others" if it is continuation-only?

The information provided notes that although eligibility is listed broadly as "Others," the continuation-only language constrains eligibility in practical terms to previously selected recipients funded under the prior award.